Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening

Area of Science:

• Drug Discovery and Development
• Parasitology
• Biotechnology

Background:

• Radioisotopic assays for antimalarial drug screening are expensive, complex, and require specialized safety measures.
• These limitations hinder their application in high-throughput drug testing environments.
• There is a need for simpler, more cost-effective, and safer assay methods.

Purpose of the Study:

• To develop and validate a novel, one-step fluorescence assay for antimalarial drug screening.
• To compare the performance of the new fluorescence assay with a standard radioisotopic method.
• To assess the suitability of the fluorescence assay for high-throughput antimalarial drug discovery.

Main Methods:

• Parasite growth determination using SYBR Green I, a fluorescent dye that binds to Plasmodium DNA.
• Side-by-side comparison with a standard radioisotopic assay.
• Testing known antimalarial drugs against Plasmodium falciparum strain D6.
• Calculation of the effective concentration (EC50) for 50% parasite growth inhibition after 48 hours.

Main Results:

• The fluorescence assay demonstrated comparable or identical EC50 values to the radioisotopic method for tested antimalarial drugs.
• Chloroquine, quinine, mefloquine, artemisinin, and a xanthone derivative showed consistent results between both assay techniques.
• The new assay is simple, robust, and inexpensive to implement.

Conclusions:

• The SYBR Green I-based fluorescence assay is a viable and effective alternative to radioisotopic methods for antimalarial drug screening.
• This assay is well-suited for high-throughput screening due to its simplicity and cost-effectiveness.
• The findings support the adoption of this fluorescence assay in antimalarial drug discovery programs.